(Q39870740)

15 September 2017

title

Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer (English)

1 reference

15 September 2017

0 references

1 reference

2

1 reference

15 September 2017

Hela Masmoudi

1

1 reference

15 September 2017

Nicholas Petrick

series ordinal

3

1 reference

15 September 2017

Kyle J Myers

series ordinal

4

1 reference

15 September 2017

Marios A Gavrielides

series ordinal

5

1 reference

15 September 2017

publication date

19 January 2009

1 reference

IEEE Transactions on Medical Imaging

15 September 2017

published in

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

916-925

1 reference

Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53

15 September 2017

cites work

1 reference

12 December 2020

Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

1 reference

12 December 2020

Immunohistochemistry and quantitative analysis of protein expression

1 reference

12 December 2020

Automated evaluation of Her-2/neu status in breast tissue from fluorescent in situ hybridization images.

1 reference

12 December 2020

Assessment of medical imaging systems and computer aids: a tutorial review

1 reference

12 December 2020

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome

1 reference

12 December 2020

The clinical evaluation of HER-2 status: which test to use?

1 reference

12 December 2020

Tissue microarrays: bridging the gap between research and the clinic

1 reference

12 December 2020

Histopathologic characteristics predicting HER-2/neu amplification in breast cancer

1 reference

12 December 2020

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

1 reference

12 December 2020

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

1 reference

12 December 2020

The Akt pathway in human breast cancer: a tissue-array-based analysis

1 reference

12 December 2020

Interpretation and quantification of immunostains

1 reference

12 December 2020

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Perspectives in tissue microarrays

1 reference

12 December 2020

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab

1 reference

12 December 2020

Biomolecular prognostic factors in breast cancer.

1 reference

12 December 2020

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

1 reference

12 December 2020

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction

1 reference

12 December 2020

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

12 December 2020

Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases

1 reference

12 December 2020

HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.

1 reference

12 December 2020

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

1 reference

12 December 2020

Assessment of HER-2/neu Status in Breast Cancer

1 reference

12 December 2020

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis

1 reference

12 December 2020

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

12 December 2020

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

1 reference

12 December 2020

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

1 reference

12 December 2020

Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest

1 reference

12 December 2020

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion

1 reference

12 December 2020

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

1 reference

12 December 2020

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

1 reference

12 December 2020

HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system

1 reference

12 December 2020

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

1 reference

12 December 2020

Molecular Signatures of Breast Cancer — Predicting the Future

1 reference

12 December 2020

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

1 reference

12 December 2020

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

12 December 2020

Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis

1 reference

12 December 2020

Automated subcellular localization and quantification of protein expression in tissue microarrays.

1 reference

12 December 2020

Is fluorescence in situ hybridization really superior to HercepTest?

1 reference

12 December 2020

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

12 December 2020

Breast cancer biomarkers and molecular medicine: part II.

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

Breast cancer biomarkers and molecular medicine

1 reference

12 December 2020

Measurement of observer agreement

1 reference

12 December 2020

Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

1 reference

12 December 2020

Cooperation of color pixel classification schemes and color watershed: a study for microscopic images.

1 reference

12 December 2020

TOR signaling in growth and metabolism

1 reference

12 December 2020

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

1 reference

12 December 2020

Skin segmentation using color pixel classification: analysis and comparison.

1 reference

12 December 2020

Identifiers

DOI

10.1109/TMI.2009.2012901

1 reference

journals/tmi/MasmoudiHPMG09

15 September 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference